BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2015
View Archived Issues
Novel synthetic method for position-selective labeling of RNAs
Read More
Phylogica and the University of Queensland receive grant for macrocylic phylomer drugs
Read More
Saphris sublingual tablets launched in the U.S. for bipolar I disorder in pediatric patients
Read More
First-in-human trial of the postexposure tuberculosis vaccine H56:IC31 in healthy adults
Read More
MoA studies of potent organo-osmium compound reveal potential new anticancer strategy
Read More
Negative modulators of alpha5-containing GABA(A) receptors show rapid antidepressant action
Read More
FDA grants orphan drug designation to C2N-8E12 for progressive supranuclear palsy
Read More
PhaseRx selects lead program to advance into clinic for orphan liver disease indication
Read More
Recro Pharma reports positive phase II data for Dex-IN in postsurgical pain
Read More
Altamira Bio acquires NIH license and CRADAs for ManNAc
Read More
ETC-159 begins phase I study in Singapore for advanced solid tumors
Read More
Merck & Co. discloses ERK2 inhibitors
Read More
Asana BioSciences presents P2X3 and/or P2X2/3 antagonists
Read More
Gilead patents MAP3K5 inhibitors
Read More
Calitor introduces JAK inhibitors
Read More
ArmaGen opens enrollment in phase I study of AGT-181 for MPS I
Read More
Bayer initiates phase I trial of BAY-1143269 with docetaxel for advanced solid tumors
Read More
Purdue Pharma patents morphinan analogs
Read More
Aquinnah Pharmaceuticals receives ALS Association funding to target TDP-43
Read More
Viekira Pak receives FDA orphan drug designation for hepatitis C in pediatric patients
Read More
Anti-MMP-9 MAb wins U.S. orphan drug designation for gastric cancer
Read More
